Back
Allogene Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
15
ALLO
Allogene Therapeutics
Last Price:
2.27
Seasonality Move:
6.59%
Buy
71
PLX
Protalix BioTherapeutics
Last Price:
1.39
Seasonality Move:
78.33%
Sell
15
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.27. The Score for ALLO is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.40. The Score for PLX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 36.04 | Sell |
Chaikin Money Flow: | -2840160 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.54 - 3) | Sell |
Bollinger Bands (100): | (2.41 - 2.95) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 67.1 | Buy |
Chaikin Money Flow: | 245801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.06 - 1.28) | Buy |
Bollinger Bands (100): | (0.98 - 1.18) | Buy |
ALLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.86 | Sell |
20-day SMA: | 2.78 | Sell |
50-day SMA: | 2.75 | Sell |
200-day SMA: | 3.17 | Sell |
8-day EMA: | 2.69 | Sell |
20-day EMA: | 2.76 | Sell |
50-day EMA: | 2.74 | Sell |
200-day EMA: | 3.07 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Buy |
20-day SMA: | 1.19 | Buy |
50-day SMA: | 1.11 | Buy |
200-day SMA: | 1.18 | Buy |
8-day EMA: | 1.3 | Buy |
20-day EMA: | 1.22 | Buy |
50-day EMA: | 1.14 | Buy |
200-day EMA: | 1.21 | Buy |
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Allogene Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |